The Seattle Times

1 of 2
Justin Ferland Photography
Advertising

Friday, September 7, 2012

Urgent pleas from parents greet biotech's new drug

Jenn Mcnary's sons, Austin, 13, left, and Max, 10, were born with Duchenne muscular dystrophy, a degenerative neuromuscular disorder causing severe, progressive muscle loss and a premature death. Max is participating in a clinical trial of Sarepta Therapeutics' drug Eteplirsen.